AR064319A1 - Compuestos y composiciones farmaceuticas derivadas de sulfonamida ciclicos, proceso de preparacion y usos en el tratamiento de trastornos vasomotrices, sexuales, gastrointestinales y otros - Google Patents

Compuestos y composiciones farmaceuticas derivadas de sulfonamida ciclicos, proceso de preparacion y usos en el tratamiento de trastornos vasomotrices, sexuales, gastrointestinales y otros

Info

Publication number
AR064319A1
AR064319A1 ARP070105586A ARP070105586A AR064319A1 AR 064319 A1 AR064319 A1 AR 064319A1 AR P070105586 A ARP070105586 A AR P070105586A AR P070105586 A ARP070105586 A AR P070105586A AR 064319 A1 AR064319 A1 AR 064319A1
Authority
AR
Argentina
Prior art keywords
alkyl
substituted
occurrence
independently
halo
Prior art date
Application number
ARP070105586A
Other languages
English (en)
Inventor
Charles W Mann
Joseph P Sabatucci
Joel A Goldberg
Richard P Woodworth
Casey C Mccomas
Andrew Fensome
Edward G Melenski
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of AR064319A1 publication Critical patent/AR064319A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/02—1,2-Thiazines; Hydrogenated 1,2-thiazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/15—Six-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D291/00—Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms
    • C07D291/08—Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D419/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms
    • C07D419/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D419/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D419/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms
    • C07D419/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D419/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Reivindicacion 1: Un compuesto de formula (1) o una sal farmacéuticamente aceptable de este; caracterizado porque: m es un entero de 0 a 4; n es un entero de 0 a 2; p es un entero de 0 a 1; q es un entero de 1 a 2; v es un entero de 0 a 2; X es C(R11)2, N(R12), O, o S(O)v; Y es C(R11)2, N(R12), O (2); R1 es arilo sustituido con 0-3 R5 o heteroarilo sustituido con 0-3 R5; R2 es H, alquilo C1-6 recto o ramificado, cicloalquilo C3-6, o arilalquilo C1-6 en donde dicha porcion arilo se sustituye con 0-3 R6; R3 es H, alquilo C1-6 recto o ramificado, alcanol C1-6, cicloalquilo C3-6, o arilalquilo C1-6 en donde dicha porcion arilo se sustituye con 0-3 R7; o R2 y R3, junto con el nitrogeno al cual ellos se adhieren, forman un anillo mono- o bicíclico heterocíclico de 3 a 12 átomos en el anillo, en donde un carbono se puede reemplazar opcionalmente con N, O, S, o SO2, y en donde cualquier átomo de carbono en el anillo se puede sustituir opcionalmente con alquilo C1-4, F, o CF3 o en donde cualquier átomo de N adicional se puede sustituir opcionalmente con alquilo C1-4 con la condicion que si Y es O o N(R12), q no es 2; R4 es H, alquilo C1-6 recto o ramificado, arilo sustituido con 0-3 R8, arilalquilo C1-6 en donde dicha porcion arilo se sustituye con -3 R8, heteroarilo sustituido con 0-3 r8, o heteroarilalquilo C1-6 en donde dicha porcion heteroarilo se sustituye con 0-3 R8; R5 es, independientemente en cada ocurrencia, alquilo C1-6, alcoxi, halo, CF3, OCF3, hidroxi, alcanoiloxi, nitro, nitrilo, alquenilo, alquinilo, arilo sustituido con 0-3 R5 o heteroarilo sustituido con 0-3 R5; R6 es, independientemente en cada ocurrencia, alquilo C1-4, halo o H; R7 es, independientemente en cada ocurrencia, alquilo C1-4, halo o H; R8 es, independientemente en cada ocurrencia, alquilo C1-4, halo o H; R9 es, independientemente en cada ocurrencia, alquilo C1-6, alcoxi, halo, H, CF3, OCF3, hidroxi, alcanoiloxi, nitro, nitrilo, alquenilo, alquinilo, arilo sustituido con 0-3 R10, heteroarilo sustituido con 0-3 R10, alquilsulfoxido, alquilsulfona, alquilsulfonamida, fenilsulfonamida sustituida con 0-3 R10, alquilamido, o arilamido sustituido con -3 R10; o dos R9 adyacentes, junto con los átomos en el anillo a los cuales ellos se adhieren, forman un anillo fusionado de 5 o 6 átomos en el anillo; R10 es, independientemente en cada ocurrencia, H, alquilo C1-6, o halo; R11 es independientemente en cada ocurrencia, H, alquilo C1-6, halo, hidroxi, O- (alquilo C1-6), o arilo sustituido con 0-3 R8; R12 es, independientemente en cada ocurrencia, H, alquilo C1-6, o arilo sustituido con 0-3 R8; R13 es, independientemente en cada ocurrencia, H, alquilo C1-6, haluro, hidroxi, o arilo sustituido con 0-3 R16 o haluro; R15 es, independientemente en cada ocurrencia, H, alquilo C1-4 o haluro; R16 es, independientemente en cada ocurrencia, H, alquilo C1-4, o halo; R17 es, independientemente en cada ocurrencia, H, o alquilo C1.4, en donde el anillo A es fenilo, naftilo, piridilo, pirimidinilo, tienilo, tiazolilo, o pirrolilo.
ARP070105586A 2006-12-12 2007-12-12 Compuestos y composiciones farmaceuticas derivadas de sulfonamida ciclicos, proceso de preparacion y usos en el tratamiento de trastornos vasomotrices, sexuales, gastrointestinales y otros AR064319A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US86964206P 2006-12-12 2006-12-12

Publications (1)

Publication Number Publication Date
AR064319A1 true AR064319A1 (es) 2009-03-25

Family

ID=39345330

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP070105586A AR064319A1 (es) 2006-12-12 2007-12-12 Compuestos y composiciones farmaceuticas derivadas de sulfonamida ciclicos, proceso de preparacion y usos en el tratamiento de trastornos vasomotrices, sexuales, gastrointestinales y otros

Country Status (6)

Country Link
US (1) US20080171737A1 (es)
AR (1) AR064319A1 (es)
CL (1) CL2007003591A1 (es)
PE (1) PE20081577A1 (es)
TW (1) TW200831476A (es)
WO (1) WO2008073956A2 (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005079726A1 (en) 2004-02-23 2005-09-01 Fisher & Paykel Healthcare Limited Breathing assistance apparatus
ES2703450T3 (es) 2004-04-02 2019-03-08 Fisher & Paykel Healthcare Ltd Aparato de asistencia a la respiración
DE202007019687U1 (de) 2006-07-14 2015-07-14 Fisher & Paykel Healthcare Ltd. Atemhilfsgerät
US10258757B2 (en) 2008-05-12 2019-04-16 Fisher & Paykel Healthcare Limited Patient interface and aspects thereof
US10792451B2 (en) 2008-05-12 2020-10-06 Fisher & Paykel Healthcare Limited Patient interface and aspects thereof
US11660413B2 (en) 2008-07-18 2023-05-30 Fisher & Paykel Healthcare Limited Breathing assistance apparatus
US9901700B2 (en) 2008-10-10 2018-02-27 Fisher & Paykel Healthcare Limited Nasal pillows for a patient interface
EP3741418B1 (en) 2009-11-18 2024-05-08 Fisher & Paykel Healthcare Limited Nasal interface
EP3406287B1 (en) 2010-10-08 2022-04-27 Fisher & Paykel Healthcare Limited Respiratory mask assembly for breathing assistance apparatus
CN102464627A (zh) * 2010-11-10 2012-05-23 上海药明康德新药开发有限公司 丙烯基-1,3-磺内酰胺的制备方法
WO2012120052A1 (de) * 2011-03-08 2012-09-13 Sanofi Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
WO2012120057A1 (de) * 2011-03-08 2012-09-13 Sanofi Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
WO2012120055A1 (de) * 2011-03-08 2012-09-13 Sanofi Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
US8828995B2 (en) 2011-03-08 2014-09-09 Sanofi Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
US10603456B2 (en) 2011-04-15 2020-03-31 Fisher & Paykel Healthcare Limited Interface comprising a nasal sealing portion
AU2012241516B2 (en) 2011-04-15 2016-06-16 Fisher & Paykel Healthcare Limited Interface comprising a rolling nasal bridge portion
SG11201407402TA (en) 2012-05-11 2014-12-30 Reset Therapeutics Inc Carbazole-containing sulfonamides as cryptochrome modulators
CN104602745B (zh) 2012-08-08 2017-09-26 费雪派克医疗保健有限公司 用于患者接口的头帽
US9950130B2 (en) 2012-09-04 2018-04-24 Fisher & Paykel Healthcare Limited Valsalva mask
CN104812382A (zh) 2012-09-20 2015-07-29 坦普尔大学 取代的烷基二芳基衍生物、制备方法和用途
TWI690521B (zh) 2014-04-07 2020-04-11 美商同步製藥公司 作為隱花色素調節劑之含有咔唑之醯胺類、胺基甲酸酯類及脲類
WO2016032343A1 (en) 2014-08-25 2016-03-03 Fisher & Paykel Healthcare Limited Respiratory mask and related portions, components or sub-assemblies
WO2016188806A1 (de) 2015-05-22 2016-12-01 Basf Se Beta-naphtholethersulfonate, verfahren zu deren herstellung und deren verwendung als glanzverbesserer
WO2018007323A1 (en) * 2016-07-04 2018-01-11 Bayer Cropscience Aktiengesellschaft Benzosultams and analogues and their use as fungicides
USD824020S1 (en) 2017-02-23 2018-07-24 Fisher & Paykel Healthcare Limited Cushion assembly for breathing mask assembly
USD823454S1 (en) 2017-02-23 2018-07-17 Fisher & Paykel Healthcare Limited Cushion assembly for breathing mask assembly
USD823455S1 (en) 2017-02-23 2018-07-17 Fisher & Paykel Healthcare Limited Cushion assembly for breathing mask assembly
CN111559990B (zh) * 2020-05-29 2021-03-09 四川大学华西医院 一种小分子噁噻嗪类衍生物及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3041336A (en) * 1958-10-01 1962-06-26 Norwich Pharma Co 3-oxo-1.2.6-thiadiazine-1.1-dioxides
US3303190A (en) * 1965-03-11 1967-02-07 Smith Kline French Lab Novel dihydro-2, 1-benzothiazine-2, 2-dioxide compounds
DE1811717A1 (de) * 1968-11-29 1970-06-11 Bayer Ag 2,4-Dicyano-6-nitrophenyl-Derivate
GB2362381A (en) * 2000-05-18 2001-11-21 Lilly Co Eli Pharmaceutically active indolyl-piperidines
US7414052B2 (en) * 2004-03-30 2008-08-19 Wyeth Phenylaminopropanol derivatives and methods of their use
WO2006000902A1 (en) * 2004-06-25 2006-01-05 Pfizer Products Inc. Dihydrobenzofuran compounds and uses thereof
WO2006121922A1 (en) * 2005-05-06 2006-11-16 Neurocrine Biosciences, Inc. Monoamine re-uptake inhibitors and methods relating thereto

Also Published As

Publication number Publication date
WO2008073956A2 (en) 2008-06-19
PE20081577A1 (es) 2008-11-28
WO2008073956A3 (en) 2008-07-24
US20080171737A1 (en) 2008-07-17
CL2007003591A1 (es) 2008-02-29
TW200831476A (en) 2008-08-01

Similar Documents

Publication Publication Date Title
AR064319A1 (es) Compuestos y composiciones farmaceuticas derivadas de sulfonamida ciclicos, proceso de preparacion y usos en el tratamiento de trastornos vasomotrices, sexuales, gastrointestinales y otros
EA200900358A1 (ru) Энантиомерно чистые фосфоиндолы в качестве ингибиторов hiv
AR083367A1 (es) Compuestos de tipo quinazolinona como antagonistas de crth
AR058065A1 (es) Compuestos de carboxiamina y uso de los mismos.composiciones farmaceuticas.
AR054787A1 (es) Derivados de piperidinas utiles como antagonistas de histamina h3
RS53153B (en) ANTAGONISTS OF HYSTAMINE -3 RECEPTORS
AR056327A1 (es) Compuestos de nucleosidos para el tratamiento de infecciones virales
AR048939A1 (es) Derivados de fenol y tiofenol 3 - o 4 - monosustituidos utiles como ligandos de h3; composiciones farmaceuticas que los contienen y su uso en la fabricacion de medicamentos para el tratamiento de trastornos neurologicos e inflamatorios.
PE20140863A1 (es) Compuestos de benceno sustituidos con arilo o heteroarilo
HRP20120695T1 (hr) 8-supstituirani benzoazepini kao modulatori toll-u sličnog receptora
HRP20080113T3 (en) Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
HRP20090627T1 (hr) Inhibitori hcv ns3 proteaze
EA201171328A1 (ru) Производное замещенного изохинолина
WO2002025376A3 (en) Oxime derivatives and the use thereof as latent acids
CU23926B1 (es) Derivado de oxopirazina y herbicida
EA201070235A1 (ru) Новые производные 6-триазолпиридинсульфанил-бензотиазола и -бензимидазола, способ их получения, применение их в качестве лекарственных средств, фармацевтические композиции и новое применение, а именно в качестве ингибиторов met
UY29312A1 (es) Piperazin-1-carboxamidas n,4,sustituidas y sus derivados, composiciones que los contienen, procedimientos de preparación y aplicaciones
ATE484502T1 (de) Neue verbindungen
EA200870192A1 (ru) Новые серосодержащие производные циклической мочевины, их получение и их фармацевтическое применение в качестве ингибиторов киназ
AR015312A1 (es) Compuestos inhibidores no peptidilicos de la union a las celulas dependientes de vla-4 utiles en el tratamiento de enfermedades inflamatorias, autoinmunesy respiratorias, composicion farmaceutica y uso de los compuestos en la preparacion de medicamentos
TN2011000380A1 (en) Triazolopyridine derivatives as p38 map kinase inhibitors
AR064318A1 (es) Compuesto y composicion derivada de aril sulfamida, uso del compuesto y proceso para la preparacion del compuesto
NI201000134A (es) Nuevos derivados dihidroindolonas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
RU2009102270A (ru) Производные тиазолилмочевины в качестве ингибиторов фосфатидилинозитол-3-киназы
AR048447A1 (es) Derivados fenilaminopropanol, composiciones farmaceuticas que los contienen y usos como moduladores de la recaptacion de monoaminas

Legal Events

Date Code Title Description
FB Suspension of granting procedure